Although the lymphocyte count correlates well with declining CD-4 cells and thus progression of disease, we are not aware of recommendations to use this expeditiously on admission, i.e., that with AIDS as a possibility, empiric therapy for PCP should be initiated if the lymphocyte count is low, while the other tests are still pending. This evidence concerns the gene CD4 and AIDS.